AI assistant
Sending…
LIGAND PHARMACEUTICALS INC — Director's Dealing 2011
Nov 10, 2011
31289_dirs_2011-11-10_f0e09018-1202-42e4-80a4-7df0f21377bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGNDD)
CIK: 0000886163
Period of Report: 2011-11-10
Reporting Person: Patel Sunil (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-10 | Common Stock | P | 800.0 | $11.109 | Acquired | 26505.0 | Direct |
| 2011-11-10 | Common Stock | P | 1700.0 | $11.11 | Acquired | 28205.0 | Direct |
More from LIGAND PHARMACEUTICALS INC
Proxy Solicitation & Information Statement
2026
May 18
M&A Activity
2026
May 18
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 7
Major Shareholding Notification
2026
May 1
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 27
M&A Activity
2026
Apr 27
Annual Report
2026
Apr 21